These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3872305)

  • 21. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine deaminase, nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase activity in normal lymphocyte subpopulations.
    Davis S; Rambotti P
    Anticancer Res; 1982; 2(3):125-8. PubMed ID: 6812486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme activity and distribution of adenosine deaminase types in a population of central Italy.
    Lucarini N; Borgiani P
    Hum Hered; 1989; 39(6):322-6. PubMed ID: 2613260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
    Lowe JK; Gowans B; Brox L
    Cancer Res; 1977 Sep; 37(9):3013-7. PubMed ID: 301772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
    Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of one of two adenosine deaminase alleles in a human choriocarcinoma cell line following selection with adenine nucleosides.
    Yeung CY; Riser ME; Kellems RE; Siciliano MJ
    J Biol Chem; 1983 Jul; 258(13):8330-7. PubMed ID: 6683274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic expression of adenosine deaminase in human lymphoid malignancies.
    Gan TE; Dadonna PE; Mitchell BS
    Blood; 1987 May; 69(5):1376-80. PubMed ID: 3567360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of murine adenosine deaminase (ADA) in transgenic maize.
    Petolino JF; Young S; Hopkins N; Sukhapinda K; Woosley A; Hayes C; Pelcher L
    Transgenic Res; 2000 Feb; 9(1):1-9. PubMed ID: 10853264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of adenosine deaminase for lymphocyte development and function.
    Aldrich MB; Blackburn MR; Kellems RE
    Biochem Biophys Res Commun; 2000 Jun; 272(2):311-5. PubMed ID: 10833410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
    Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between adenosine deaminase and a human thymus leukemia antigen isolated from MOLT 4 cells.
    Dowell BL; Segars JH; Metzgar RS
    Cancer Res; 1981 Jan; 41(1):343-5. PubMed ID: 7192600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
    Blackburn MR; Kellems RE
    Adv Immunol; 2005; 86():1-41. PubMed ID: 15705418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
    Tsuchiya S; Nakae S; Konno T; Tada K
    J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of the regional localization of the genes for human acid alpha-glucosidase (GAA) and adenosine deaminase (ADA) by somatic cell hybridization.
    Honig J; Martiniuk F; D'Eustachio P; Zamfirescu C; Desnick R; Hirschhorn K; Hirschhorn LR; Hirschhorn R
    Ann Hum Genet; 1984 Jan; 48(1):49-56. PubMed ID: 6370091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer and expression of human ADA in murine hematopoietic stem cells.
    Williams DA; Lim B; Orkin SH
    Prog Clin Biol Res; 1987; 251():567-80. PubMed ID: 3432278
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic heterogeneity in partial adenosine deaminase deficiency.
    Hirschhorn R; Martiniuk F; Roegner-Maniscalco V; Ellenbogen A; Perignon JL; Jenkins T
    J Clin Invest; 1983 Jun; 71(6):1887-92. PubMed ID: 6863546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.